世界の急性腹部外傷治療市場 – 2030 年までの業界動向と予測

急性腹部外傷治療市場分析と規模

自動車事故、転倒、職場での怪我などの外傷事件の増加は、急性腹部外傷治療の需要を促進する可能性があります。さらに、高齢化人口の増加、都市化、ライフスタイルの変化が急性腹部外傷治療の急増に寄与しており、2023〜2030年の予測期間内に世界の急性腹部外傷治療市場の成長を促進する可能性があります。近年、技術の進歩により、腹部外傷治療の設計と機能に革命が起こりました。診断画像、外科技術、低侵襲手術の改善を含む医療技術の進歩は、急性腹部外傷に対するより優れた、より効果的な治療につながる可能性があり、これはさらに、上記の予測期間内に世界の急性腹部外傷治療市場の成長につながる大きな機会を生み出すことによって貢献します。

データブリッジ市場調査は、2022年に4億4,418万米ドルであった世界の急性腹部外傷治療市場は、2030年までに5億4,268万米ドルに達し、2023年から2030年の予測期間中に2.6％のCAGRで成長すると予測しています。これは、市場価値を示しています。急性腹部外傷治療市場のエンドユーザーセグメントでは、「病院」が主流であり、これは病院での症例の増加によるものです。データブリッジ市場調査がまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、詳細な専門家の分析、患者の疫学、パイプライン分析、価格設定分析、規制の枠組みも含まれています。

急性腹部外傷治療市場の範囲とセグメンテーション

Market Definition

The “Acute Abdomen” is defined as sudden onset severe abdominal pain. Within this, there are large number of possible causes, including serious and life-threatening conditions, and therefore a structured approach is essential to ensure appropriate triage and timely management.

Global Acute Abdomen Trauma Treatment Market Dynamics

Drivers

• Increasing Prevalence of Trauma Incidence

The increase in trauma incidence across the globe acts as one of the major factors driving the growth of global acute abdomen trauma treatment market. An increase in trauma cases, such as motor vehicle accidents, falls, and workplace injuries, can drive the demand for acute abdomen trauma treatment. Population growth, urbanization, and changing lifestyles can contribute to higher trauma incidence.

Moreover, chronic medical conditions, such as obesity and diabetes, can increase the risk of abdominal injuries in some individuals, necessitating the need for acute abdomen trauma treatment.

• Rising Number of Geriatric Population

Expanding geriatric population worldwide is predicted to favour the injuries cases as this population is more prone to develop abdomen diseases. The number of persons above 65 years is projected to double in the coming years. The rise in the geriatric population accelerate the market growth as ageing population is highly susceptible to trauma, which can foster the demand for the acute abdomen trauma cases across the globe.

According to the United Nations, there were around 382 million old age people, aged 60 years or above, across the globe in 2017 and this number is expected 2.1 billion by 2050.

• Increasing Healthcare Expenditure

Greater healthcare expenditure, both by governments and private entities, can provide healthcare facilities with more resources to invest in advanced trauma care equipment and treatments. Thus, demand for treatment has driven the development of new technologies which further fuel the growth during market in the forecast period.

Moreover, increasing awareness about the importance of early diagnosis and treatment of abdominal trauma can lead to more patients seeking medical care, which will further act as driver that will lead to the growth of the acute abdomen trauma treatment market in the above mentioned projected timeframe.

Opportunity

• Rising Technological Advancements

Advances in medical technology, including improvements in diagnostic imaging, surgical techniques, and minimally invasive procedures, can lead to better and more effective treatments for acute abdomen trauma and will extend profitable opportunities for the market players in the forecast period of 2023 to 2030.

Additionally, the trend toward minimally invasive surgery techniques, such as laparoscopy, can reduce patient recovery times and hospital stays, which will further contribute by generating immense opportunities that will further expand the market's growth rate in the future. 

Restraint/Challenge

• Rising Patient Severity and Complexity

On the other hand, trauma patients with acute abdomen injuries often present with severe and complex conditions that require immediate and specialized care. Managing these patients can be challenging due to the diversity of injuries and associated complications, will likely to act as market restraints factor for the growth of the acute abdomen trauma market in the above mentioned projected timeframe. Moreover, the cost of trauma care can be expensive, especially when surgical interventions and prolonged hospital stays are required. Managing the cost of care while delivering high-quality treatment will become the biggest and foremost challenge for the growth of the market in the forecast period of 2023-2030.

This global acute abdomen trauma treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global acute abdomen trauma treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In September 2020, DJO will release the DonJoy X-ROM Post-Op Knee Brace. The product is stated to be one of the most advanced range of motion (ROM) protection, with an improved user-friendly design for quicker and faster application and adjustment. The X-ROM brace aids patients in their recovery after ACL reconstruction and other knee procedures. It increases comfort, stability, and confidence

Global Acute Abdomen Trauma Treatment Market Scope

The acute abdomen trauma treatment market is segmented on the basis of types, mechanism, drug type, treatment type, drug class, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Types

• Abdominal Wall
• Solid Organ
• Liver
• Spleen
• Pancreas
• Kidneys
• Hollow Viscus
• Stomach
• small intestine
• colon
• ureters
• bladder
• Vasculature

Mechanism

• Blunt Trauma
• Penetrating Injuring

Drug Type

• Analgesics
• Antibiotics
• Supportive Care

Treatment Type

• Solid Oral
• Tablets
• Pills
• Capsule
• Others
• Liquid
• Syrups
• Ointments
• Others
• Parenteral
• Intravenous
• Intramuscular
• Subcutaneous
• Others
• Others

Drug Class

• Drug used in Blunt Trauma
• Analgesic
• Antibiotics
• Drug in Penetrating trauma
• Analgesic
• Anxiolytics
• Antibiotics
• Neuromuscular Blocking Agents
• Immune Enhancer

End User

• Hospitals
• Ambulatory Services
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• online Pharmacies
• Others

Global Acute Abdomen Trauma Treatment Market Regional Analysis/Insights

The global acute abdomen trauma treatment market is analyzed and market size insights and trends are provided by country, types, mechanism, drug type, treatment type, drug class, end user and distribution channel.

The countries covered in the global acute abdomen trauma treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the global acute abdomen trauma treatment market due to excellent hospital and ambulatory trauma services and better reimbursement policies.

Asia-Pacific is expected to grow at the highest growth rate during the forecast period of 2023 to 2030 owing to the increase in healthcare insurance provided by private companies and emerging healthcare facilities in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global acute abdomen trauma treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global acute abdomen trauma treatment market , impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global acute abdomen trauma treatment market. The data is available for historic period 2015-2020.

Competitive Landscape and Acute Abdomen Trauma Treatment Market Share Analysis

The global acute abdomen trauma treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global acute abdomen trauma treatment market.

Some of the major players operating in the global acute abdomen trauma treatment market are:

• Sanofi (France)
• Hi-Tech Pharma (U.S.)
• マリンクロット（英国）
• ヒクマ・ファーマシューティカルズPLC（米国）
• ファイザー社（米国）
• フレゼニウス カビ USA (米国)
• テバ製薬株式会社（イスラエル）
• レシファームAB（スウェーデン）
• ノバルティスAG（スイス）
• アボットラボラトリーズ（米国）
• ブリストル・マイヤーズスクイブ（米国）
• ロシュ・ラボラトリーズ（スイス）
• グラクソ・スミスクライン（英国）
• グレンマーク・ファーマシューティカルズ・リミテッド（インド）
• メルク社（米国）
• サン・ファーマシューティカル・インダストリーズ（インド）

SKU-60630